Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2017

View Archived Issues

Tonix discloses successful synthesis of potential smallpox-preventing vaccine

Staten Biotech exercises option to license ARGX-116 from collaboration with argenx

Lin BioScience licenses CDC7 inhibitor from Columbia University and Memorial Sloan Kettering

XW Laboratories licenses mitochondria targeted bis-nitroxide compounds from University of Pittsburgh

APPROACH phase III study of volanesorsen in familial chylomicronemia syndrome meets primary endpoint

Novan to proceed with SB-204 development

Galectin reports phase IIa findings on GR-MD-02 in plaque psoriasis

RgIA4 prevents chemotherapy-induced neuropathic pain in preclinical models

Fixed-dose combination of oxybutynin and pilocarpine is effective in treating hyperhidrosis

European Commission approves Ledaga for mycosis fungoides-type CTCL

First-in-human study of IPI-549 presented at Targeted Anticancer Therapies conference

IMDC recommends continuation of phase IIb study of BGS-649 for hypogonadotropic hypogonadism

Ataxion to merge with Luc Therapeutics

Grant supports Novogen's next-generation anti-tropomyosin program

Deciphera initiates phase I study of DCC-3014

Promising topline data from phase III GENUINE study of TG-1101 in CLL

FDA clears IND for ADXS-NEO

SOX17 found to be a prognostic factor in endometrial carcinoma

FDA lifts clinical hold on phase I trials of vadastuximab talirine

FDA acknowledges filing over protest of Translarna NDA for DMD

Eli Lilly identifies novel calcitonin gene-related peptide receptor antagonists

Grants support development by Vaxess of microneedle vaccines for polio, measles and rubella

Boehringer Ingelheim discloses epithelial sodium channel blockers

Vertex to acquire Concert's CTP-656 for cystic fibrosis

FDA and EMA accept for filing ertugliflozin submissions

Homer-2 expression has prognostic significance in endometrial cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...